Key Takeaways
- • Pearl Health raised $110 million in a mixed financing round consisting of $50 million in equity led by Andreessen Horowitz and $60 million in debt facilities led by Trinity Capital, with participation from Viking Global Investors, AlleyCorp, and Ulysses Capital.
- • The NYC-based healthcare technology company will deploy capital to expand its AI platform focused on clinical intelligence, risk prediction, and workflow automation for Medicare patients across enterprise health systems and payers.
- • Pearl Health serves over 10,000 providers and leading health systems across more than 40 states, positioning itself as a significant player in the value-based care and Medicare Advantage segments.
- • The company is advancing Care Orchestration AI agents to automate administrative workflows including annual wellness visit scheduling and post-discharge follow-ups, addressing clinician burnout and operational efficiency challenges.
- • Under CEO Michael Kopko's leadership since its 2020 founding, Pearl Health's latest raise underscores institutional investor confidence in AI-driven solutions for population health management in the Medicare-focused market.
Summary
Pearl Health, a healthcare technology company headquartered in New York City, closed a $110 million capital raise on July 8, 2026, reinforcing investor confidence in AI-driven solutions for Medicare care management and value-based care delivery. The financing comprised two distinct tranches: a $50 million equity round led by venture capital firm Andreessen Horowitz, alongside participation from prominent institutional investors Viking Global Investors, AlleyCorp, and Ulysses Capital; and a $60 million debt facility provided by Trinity Capital, establishing a blended capital structure that balances growth equity with non-dilutive debt financing.
Pearl Health operates an AI platform designed to help healthcare providers manage patient risk, predict adverse outcomes, and automate clinical workflows before conditions escalate into costly emergency interventions. The company's Performance Intelligence offering delivers AI-driven, chat-enabled tools to population health leaders and care teams, enabling data-driven decision-making at the point of care. Founded in 2020 under the leadership of CEO Michael Kopko, Pearl has rapidly scaled to support a network exceeding 10,000 providers and leading regional health systems across more than 40 states, establishing meaningful distribution across the U.S. healthcare ecosystem.
The company intends to allocate capital toward three primary strategic objectives: expanding its AI platform to convert clinical intelligence into measurable health outcomes; accelerating growth across enterprise health system and payer partnerships; and deepening penetration into the Medicare Advantage market segment, which represents a high-growth, risk-bearing care delivery model. Pearl is concurrently advancing Care Orchestration AI agents capable of automating administrative workflows such as annual wellness visit scheduling, post-discharge follow-ups, and proactive care management outreach—functions that currently consume significant clinician time and contribute to provider burnout.
This funding announcement reflects broader institutional investor appetite for healthcare technology solutions addressing administrative inefficiency, population health management, and the economics of risk-bearing arrangements. The participation of Andreessen Horowitz, a tier-one venture capital firm with substantial healthcare technology expertise, validates Pearl Health's technology differentiation and market opportunity within the rapidly evolving Medicare and value-based care sectors.
Pearl Health operates an AI platform designed to help healthcare providers manage patient risk, predict adverse outcomes, and automate clinical workflows before conditions escalate into costly emergency interventions. The company's Performance Intelligence offering delivers AI-driven, chat-enabled tools to population health leaders and care teams, enabling data-driven decision-making at the point of care. Founded in 2020 under the leadership of CEO Michael Kopko, Pearl has rapidly scaled to support a network exceeding 10,000 providers and leading regional health systems across more than 40 states, establishing meaningful distribution across the U.S. healthcare ecosystem.
The company intends to allocate capital toward three primary strategic objectives: expanding its AI platform to convert clinical intelligence into measurable health outcomes; accelerating growth across enterprise health system and payer partnerships; and deepening penetration into the Medicare Advantage market segment, which represents a high-growth, risk-bearing care delivery model. Pearl is concurrently advancing Care Orchestration AI agents capable of automating administrative workflows such as annual wellness visit scheduling, post-discharge follow-ups, and proactive care management outreach—functions that currently consume significant clinician time and contribute to provider burnout.
This funding announcement reflects broader institutional investor appetite for healthcare technology solutions addressing administrative inefficiency, population health management, and the economics of risk-bearing arrangements. The participation of Andreessen Horowitz, a tier-one venture capital firm with substantial healthcare technology expertise, validates Pearl Health's technology differentiation and market opportunity within the rapidly evolving Medicare and value-based care sectors.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.